Webinars on circulatory health and COVID-19

Last update: 08/07/2020

The association between circulatory risk factors and pathologies and the COVID-19 pandemic is becoming more obvious as more people affected receive treatment worldwide. Each member of the Global Coalition for Circulatory Health (GCCH), which brings together international, regional and national stakeholders in circulatory health to drive the urgent action needed to combat heart disease and stroke, has been working actively within its own speciality and constituencies to provide relevant and timely information related to the crisis.

There is, however, a unique opportunity for GCCH to provide a comprehensive and global perspective on circulatory risk factors, such as hypertension, diabetes, obesity, and tobacco use, and outcomes, including renal failure, vascular problems, and cardiovascular disease, associated with COVID-19.

We are therefore delighted to invite you to join our upcoming webinar series, moderated by the World Heart Federation Past President, Prof David Wood.

COVID visual webinar logos

 

  • Circulatory Risk Factors for COVID-19, 16 June: speakers included Prof Donna Ryan (World Obesity Federation), Prof Vivek Jha (International Society of Nephrology), Prof Claudio Borghi (International Society of Hypertension) and Dr Eduardo Bianco (Framework Convention Alliance). IDF President, Prof Andrew Boulton, presented "Diabetes-related complications of the lower limb in the COVID-19 context”. 
  • COVID-19 and Circulatory Conditions: Mitigating Poor Outcomes, 30 June:  speakers included Prof Marc Fisher (World Stroke Organization), Dr Anuradha Lala-Trindade (World Heart Federation), Dr Peter Libby (International Atherosclerosis Society) and Prof Gianfranco Parati (World Hypertension League).
  • Supporting the Healthcare Workforce: COVID-19 and Public Health in the Circulatory Space, 14 July 15:00 CEST: click here to register.

The recording of the first two webinars are available below.

Circulatory Risk Factors for COVID-19 

COVID-19 and Circulatory Conditions: Mitigating Poor Outcomes

For more information, contact This email address is being protected from spambots. You need JavaScript enabled to view it.

© 2020 International Diabetes Federation Disclaimer Privacy policy